Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Distillers Company (Biochemicals) Limited was a significant British pharmaceutical manufacturer and a subsidiary of the spirits conglomerate The Distillers Company. Established in 1947, the company utilized its parent's fermentation expertise to operate a major production facility in Speke, Liverpool, becoming a leading producer of penicillin and streptomycin. The firm is most historically notable for its role in the thalidomide tragedy, having licensed and marketed the drug in the United Kingdom and Australia under the brand name Distaval. Following the drug's withdrawal and the subsequent legal crisis, the biochemical division was sold to Eli Lilly in 1962. The company's legacy is inextricably linked to the development of modern drug safety regulations and pharmacovigilance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Distillers Biochemicals.